# HE4 is a Beneficial Biomarker in Endometrial Cancer

> **NCT03459976** · — · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 87 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DIAGNOSTIC_TEST:** evaluate serum level HE4 in endometrial cancer

## Key facts

- **NCT ID:** NCT03459976
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-01
- **Primary completion:** 2019-04-01
- **Final completion:** 2019-04-01
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2019-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03459976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03459976, "HE4 is a Beneficial Biomarker in Endometrial Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03459976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*